Digestives & Intestinal Remedies - Bahrain

  • Bahrain
  • In Bahrain, the revenue in the Digestives & Intestinal Remedies market market reaches a substantial amount of US$11.36m in 2024.
  • This market is projected to experience annual growth of 3.45% from 2024 to 2029, according to the compound annual growth rate (CAGR).
  • When compared globally, in China stands as the country generating the highest revenue, reaching a staggering US$4,408.00m in 2024.
  • Taking into consideration the total population figures, the per person revenues in Bahrain's Digestives & Intestinal Remedies market market amount to US$7.58 in 2024.
  • Bahrain's growing middle class and increasing awareness of digestive health have led to a surge in demand for Digestives & Intestinal Remedies in the OTC Pharmaceuticals market.

Key regions: Brazil, India, United Kingdom, Germany, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Digestives & Intestinal Remedies market in Bahrain has been experiencing steady growth in recent years.

Customer preferences:
Bahraini consumers have shown a growing preference for natural and herbal remedies for digestive issues. They are increasingly seeking products that are made from natural ingredients and have minimal side effects. This shift in preference can be attributed to the rising awareness about the potential harmful effects of synthetic drugs and a general trend towards a more holistic approach to healthcare.

Trends in the market:
One of the key trends in the Digestives & Intestinal Remedies market in Bahrain is the increasing demand for probiotic products. Probiotics are live bacteria and yeasts that are beneficial for digestive health. They help restore the natural balance of bacteria in the gut and promote healthy digestion. The popularity of probiotic products can be attributed to the growing awareness about the importance of gut health and the role of probiotics in maintaining a healthy digestive system. Another trend in the market is the rising demand for over-the-counter (OTC) digestive remedies. Bahraini consumers are increasingly opting for self-medication and are seeking easily accessible remedies for common digestive issues such as indigestion, bloating, and heartburn. This trend can be attributed to the convenience and cost-effectiveness of OTC remedies, as well as the growing availability of these products in pharmacies and supermarkets.

Local special circumstances:
Bahrain has a high prevalence of digestive disorders, which is driving the demand for Digestives & Intestinal Remedies in the country. Factors such as unhealthy dietary habits, sedentary lifestyles, and high stress levels contribute to the high incidence of digestive issues among Bahraini population. As a result, there is a strong need for effective remedies to alleviate these symptoms and improve digestive health.

Underlying macroeconomic factors:
The growing economy of Bahrain is also contributing to the development of the Digestives & Intestinal Remedies market. As the country continues to experience economic growth, there is an increase in disposable income and a higher standard of living. This has led to an increased willingness among Bahraini consumers to spend on healthcare products, including Digestives & Intestinal Remedies. Additionally, the government's focus on improving healthcare infrastructure and promoting wellness initiatives further supports the growth of the market.In conclusion, the Digestives & Intestinal Remedies market in Bahrain is witnessing growth due to the changing customer preferences towards natural and herbal remedies, the increasing demand for probiotic products, and the rising popularity of OTC digestive remedies. The high prevalence of digestive disorders in the country and the growing economy are also contributing factors. Overall, the market is expected to continue its upward trajectory in the coming years.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)